Mohamed Khettab

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance

Yohann Loriot, Aurélien Marabelle, Jean‐Philippe Guégan et al. · Annals of Oncology · 2021 · 84 citations · Full text

Prognostic Biomarkers, Plasma Proteomics Identifies, Inhibitory Factor +10

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors

Florent Peyraud, Jean‐Philippe Guégan, D. Bodet et al. · Annals of Oncology · 2022 · 64 citations

L-arginine Predicts, Cancer Immunosurveillance, Medicine +10

Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

Alban Bessede, Aurélien Marabelle, Jean‐Philippe Guégan et al. · Annals of Oncology · 2022 · 45 citations

Cancer Immunosurveillance, Allergy, Medicine +10

Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters

Elena Manea, Alexandre Escande, Sophie Bockel et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 43 citations

Adaptive Radiotherapy, Urology, Late Urinary Complications +12

Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1

Arnaud Bayle, Mohamed Khettab, Francesca Lucibello et al. · Annals of Oncology · 2020 · 39 citations

Vaccination, Checkpoint Inhibitors, Vaccine Target +10